Advanced search
Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 46, 2016 - Issue 16
Submit an article Journal homepage
1,776
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

New synthesis route for the preparation of pomalidomide

Daowei HuangNovel Technology Center of Pharmaceutical Chemistry, Shanghai Institute of Pharmaceutical Industry, Shanghai, China;Shanghai Engineering Research Center of Pharmaceutical Process, Shanghai, China
,
Chengwu ShenShandong Provincial Hospital, Shandong University, Jinan, China
,
Wenya WangNovel Technology Center of Pharmaceutical Chemistry, Shanghai Institute of Pharmaceutical Industry, Shanghai, China;Shanghai Engineering Research Center of Pharmaceutical Process, Shanghai, China
,
Lei HuangNovel Technology Center of Pharmaceutical Chemistry, Shanghai Institute of Pharmaceutical Industry, Shanghai, China;Shanghai Engineering Research Center of Pharmaceutical Process, Shanghai, China
,
Feng NiNovel Technology Center of Pharmaceutical Chemistry, Shanghai Institute of Pharmaceutical Industry, Shanghai, China;Shanghai Engineering Research Center of Pharmaceutical Process, Shanghai, China
&
Jianqi LiNovel Technology Center of Pharmaceutical Chemistry, Shanghai Institute of Pharmaceutical Industry, Shanghai, China;Shanghai Engineering Research Center of Pharmaceutical Process, Shanghai, ChinaCorrespondence[email protected]
Pages 1343-1348 | Received 21 Jan 2016, Published online: 03 Aug 2016

References

  • Kumar, S. K.; Rajkumar, S. V.; Dispenzieri, A.; et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood 2008, 111(5), 2516–2520.
  • Scott, L. J.; Lyseng-Williamson, K. A. Lenalidomide: A review of its use in the treatment of relapsed or refractory multiple myeloma. Drugs 2011, 71(5), 625–649.
  • Singhal, S.; Mehta, J.; Desikan, R.; et al. Antitumor activity of thalidomide in refractory multiple myeloma. N. Engl. J. Med. 1999, 341(21), 1565–1571.
  • Elkinson, S.; McCormack, P. L. Pomalidomide: First global approval. Drugs 2013, 73(6), 595–604.
  • Galustian, C.; Dalgleish, A. G. Pomalidomide: TNF-α production inhibitor treatment of multiple myeloma treatment of myelofibrosis. Drugs of the Future 2011, 36(10), 741–750.
  • Ge, C.; Muller, G. W.; Chen, R.; Saindane, M. T. Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds. US Patent US20070004920A1, 2007.
  • Zhu, X. X.; Giordano, T.; Yu, Q. S.; Holloway, H. W.; Perry, T. A.; Lahiri, D. K.; Brossi, A.; Greig, N. H. Thiothalidomides: Novel isosteric analogues of thalidomide with enhanced TNF-α inhibitory activity. J. Med. Chem. 2003, 46(24), 5222–5229.
  • Perino, S.; Contino-Pepin, C.; Satchi-Fainaro, R.; Butterfield, C.; Pucci, B. Inhibition of angiogenesis by THAM-derived cotelomers endowed with thalidomide moieties. Bioorg. Med. Chem. Lett. 2004, 14(2), 421–425.
  • Ambrozak, A.; Guetschow, M. Preparation of phthalamic acid derivatives and ring closure to phthalimidobarbituric acids. J. Heterocycl. Chem. 2007, 44(6), 1259–1263.
  • Chuansheng, G.; Roger, C. Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds. CN Patent CN101253163A, 2008.
  • Webster, S. P.; Seckl, J. R.; Walker, B. R.; Ward, P.; Pallin, T. D.; Dyke, H. J.; Perrior, T. R. Amido-isothiazole compounds and their use as inhibitors of 11beta-hsd1 for the treatment of metabolic syndrome and related disorders. WO Patent WO2010/146338A1, 2010.
  • Palmer, B. D.; Ching, L. M. (2,6-Dioxo-3-piperinyl)amidobenzoic immunomodulatory and anti-cancer derivatives. WO Patent WO2008007979A1, 2008.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.